Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Anesiva, Inc.
The purpose of this study is to evaluate the efficacy, tolerability, safety, and pharmacokinetics of 4975 in patients undergoing primary unilateral total knee arthroplasty
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female aged 18 to 85 years with an American Society of Anesthesiologists (ASA) status of I, II, or III
Planning to undergo primary unilateral Total Knee Arthroplasty (TKA)
You may not be if
A body mass index (BMI) greater than 43
Known bleeding disorder or is taking agents affecting coagulation preoperatively
Use of medications or a medical condition that in the investigator's opinion could adversely impact the patient's participation or safety, conduct of the study, or interfere with the pain assessments
Diabetes mellitus with a known HbA1C\>9.5 or a history of prolonged uncontrolled diabetes
Previous knee arthroplasty (partial or total) of the same knee
Participated in another clinical trial within 30 days prior to the planned TKA surgery
